{
    "2019-09-03": [
        [
            {
                "time": "2019-09-03",
                "original_text": "What the Johnson & Johnson Opioid Ruling Means for the Cannabis Industry",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "opioid ruling",
                        "cannabis industry"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals",
                        "cannabis"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-09-03",
                "original_text": "UPDATE 1-U.S. judge orders big drug companies to face opioid trial",
                "features": {
                    "keywords": [
                        "U.S. judge",
                        "drug companies",
                        "opioid trial"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-09-03",
                "original_text": "iShares Russell 3000 ETF Experiences Big Inflow",
                "features": {
                    "keywords": [
                        "iShares",
                        "Russell 3000",
                        "ETF inflow"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "ETFs"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-09-03",
                "original_text": "The Zacks Analyst Blog Highlights: J&J, Eli Lilly, Bristol-Myers, Roche and AbbVie",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "J&J",
                        "Eli Lilly",
                        "Bristol-Myers",
                        "Roche",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-09-03",
                "original_text": "Can Roche's Blockbuster Drug Herceptin's Sales Grow?",
                "features": {
                    "keywords": [
                        "Roche",
                        "Herceptin",
                        "sales growth"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-09-03",
                "original_text": "Health Care Sector Update for 09/03/2019: CDTX, ENDP, MRK, ARDS, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health Care Sector",
                        "CDTX",
                        "ENDP",
                        "MRK",
                        "ARDS",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "AMGN"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-09-03",
                "original_text": "Bayer hires former J&J executive for more pharma deals",
                "features": {
                    "keywords": [
                        "Bayer",
                        "J&J",
                        "executive",
                        "pharma deals"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}